Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer

Clinical trial NCT00320515 · COMPLETED

Trial details

NCT number: NCT00320515
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasm, Gastric

Start date: 2004-03-01
Primary completion: 2008-07-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.